Mitsui Corp, the private equity company of Japanese multinational bought marginal stake in Guardian Lifecare, the Gurgaon-based pharmacy store. This indicates how foreign investors are keen towards 20 billion dollar pharmacy as well as wellness market of India.
A Mitsui fund put in dedicated growth capital of over 80 crore Rupees in Guardian Lifecare, a company that is engaged in retailing drugs with 230 stores in 20 cities. The company with an experience of around 10 years planned to double the network of its store to 400 by 2014.
Guardian Lifecare started selling the third-party branded products under its own brand name with over 220 stock units in various categories such as mineral water, vitamins, personal care, nutrition, sports nutrition and many more. The revenue of chain in 2011 was 110 crore Rupees.
Higher potential as well as organised wellness and Pharma chains attracted attention of foreign players in India as well.
Your career begins here! At Jagranjosh.com, our vision is to enable the youth to make informed life decisions, and our mission is to create credible and actionable content that answers questions or solves problems for India’s share of Next Billion Users. As India’s leading education and career guidance platform, we connect the dots for students, guiding them through every step of their journey—from excelling in school exams, board exams, and entrance tests to securing competitive jobs and building essential skills for their profession. With our deep expertise in exams and education, along with accurate information, expert insights, and interactive tools, we bridge the gap between education and opportunity, empowering students to confidently achieve their goals.
Latest Stories
Bengaluru to Get India's First AI City at Bidadi
National | India Current AffairsAnother Indian in NASA: Indian Origin Amit Kshatriya Got Appointed as this in NASA
International | World Current AffairsTeachers Day 2025: National Teachers Award Out; Check Full List
National | India Current Affairs
Comments
All Comments (0)
Join the conversation